Inhaltsbereich
| 71 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
 Druckansicht
|
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. |
| Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K, Halabi S, Nelson PS, Sartor O, Smith MR, Soule HR, Akaza H, Beer TM, Beltran H, Chinnaiyan AM, Daugaard G, Davis ID, De Santis M, Drake CG, Eeles RA, Fanti S, Gleave ME, Heidenreich A, Hussain M, James ND, Lecouvet FE, Logothetis CJ, Mastris K, Nilsson S, Oh WK, Olmos D, Padhani AR, Parker C, Rubin MA, Schalken JA, Scher HI, Sella A, Shore ND, Small EJ, Sternberg CN, Suzuki H, Sweeney CJ, Tannock IF, Tombal B |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Jun 3. pii: mdv257. doi: 10.1093/annonc/mdv257. pmc: PMC4511225 |
| PMID: 26041764 |
| Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. |
| Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R |
| European journal of cancer (Oxford, England : 1990). 2014 Apr 3. pii: S0959-8049(14)00253-6. doi: 10.1016/j.ejca.2014.03.010 |
| PMID: 24703899 |
| Role of salvage lymph node dissection in prostate cancer. |
| Heidenreich A, Moul JW, Shariat S, Karnes RJ |
| Current opinion in urology. 2016 Aug 31. doi: 10.1097/MOU.0000000000000343 |
| PMID: 27584024 |
| Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. |
| Gillessen S, Attard G, Beer TM, Beltran H, Bossi A, Bristow R, Carver B, Castellano D, Chung BH, Clarke N, Daugaard G, Davis ID, de Bono J, Dos Reis RB, Drake CG, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Higano CS, James N, Kantoff P, Kellokumpu-Lehtinen PL, Khauli RB, Kramer G, Logothetis C, Maluf F, Morgans AK, Morris MJ, Mottet N, Murthy V, Oh W, Ost P, Padhani AR, Parker C, Pritchard CC, Roach M, Rubin MA, Ryan C, Saad F, Sartor O, Scher H, Sella A, Shore N, Smith M, Soule H, Sternberg CN, Suzuki H, Sweeney C, Sydes MR, Tannock I, Tombal B, Valdagni R, Wiegel T, Omlin A |
| European urology. 2017 Jun 24. pii: S0302-2838(17)30497-9. doi: 10.1016/j.eururo.2017.06.002 |
| PMID: 28655541 |
| Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality. |
| Pircher A, Wolf D, Heidenreich A, Hilbe W, Pichler R, Heidegger I |
| International journal of molecular sciences. 2017 Oct 31. pii: ijms18112291. doi: 10.3390/ijms18112291 |
| PMID: 29088109 |
| External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. |
| Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A |
| World journal of urology. 2018 Aug 1. doi: 10.1007/s00345-018-2427-z. pii: 10.1007/s00345-018-2427-z |
| PMID: 30069581 |
| Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. |
| Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L |
| Prostate cancer and prostatic diseases. 2018 Aug 21. doi: 10.1038/s41391-018-0079-0. pii: 10.1038/s41391-018-0079-0 |
| PMID: 30131604 |
| Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis. |
| Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A |
| European urology. 2018 Oct 6. pii: S0302-2838(18)30659-6. doi: 10.1016/j.eururo.2018.09.009 |
| PMID: 30301694 |
| Multidisciplinary Team Meetings for Prostate Cancer Treatment: We Can Do Much Better in Daily Life. |
| Heidenreich A |
| Oncology research and treatment. 2019 May 10. pii: 000500426. doi: 10.1159/000500426 |
| PMID: 31079102 |
| External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancer. |
| Paffenholz P, Nestler T, Hoier S, Pfister D, Hellmich M, Heidenreich A |
| Urologic oncology. 2019 Sep 17. pii: S1078-1439(19)30298-4. doi: 10.1016/j.urolonc.2019.07.021 |
| PMID: 31540832 |
| Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. |
| Gillessen S, Attard G, Beer TM, Beltran H, Bjartell A, Bossi A, Briganti A, Bristow RG, Chi KN, Clarke N, Davis ID, de Bono J, Drake CG, Duran I, Eeles R, Efstathiou E, Evans CP, Fanti S, Feng FY, Fizazi K, Frydenberg M, Gleave M, Halabi S, Heidenreich A, Heinrich D, Higano CTS, Hofman MS, Hussain M, James N, Kanesvaran R, Kantoff P, Khauli RB, Leibowitz R, Logothetis C, Maluf F, Millman R, Morgans AK, Morris MJ, Mottet N, Mrabti H, Murphy DG, Murthy V, Oh WK, Ost P, O'Sullivan JM, Padhani AR, Parker C, Poon DMC, Pritchard CC, Reiter RE, Roach M, Rubin M, Ryan CJ, Saad F, Sade JP, Sartor O, Scher HI, Shore N, Small E, Smith M, Soule H, Sternberg CN, Steuber T, Suzuki H, Sweeney C, Sydes MR, Taplin ME, Tombal B, Türkeri L, van Oort I, Zapatero A, Omlin A |
| European urology. 2020 Jan 27. pii: S0302-2838(20)30048-8. doi: 10.1016/j.eururo.2020.01.012 |
| PMID: 32001144 |
| Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF Ga-PSMA and C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections. |
| Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrie A, Galosi AB, Montorsi F, Briganti A |
| The Journal of urology. 2020 Feb 18. doi: 10.1097/JU.0000000000000800 |
| PMID: 32068488 |
| Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancer. |
| Heidenreich A, Bludau M, Bruns C, Nestler T, Porres D, Pfister DJKP |
| BJU international. 2020 Apr 22. doi: 10.1111/bju.15088 |
| PMID: 32320130 |
| Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3). |
| Seidel C, Daugaard G, Nestler T, Tryakin A, Fedyanin M, Fankhauser C, Hermanns T, Aparicio J, Heinzelbecker J, Paffenholz P, Heidenreich A, De Giorgi U, Cathomas R, Lorch A, Fingerhut A, Gayer F, Bremmer F, Giannatempo P, Necchi A, Aurilio G, Casadei C, Tran B, Dieckmann KP, Brito M, Ruf C, Oing C, Bokemeyer C |
| European journal of cancer (Oxford, England : 1990). 2020 Apr 29. pii: S0959-8049(20)30163-5. doi: 10.1016/j.ejca.2020.03.022 |
| PMID: 32361383 |
| Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. |
| Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology. 2020 Jul 2. pii: S0302-2838(20)30472-3. doi: 10.1016/j.eururo.2020.06.043 |
| PMID: 32624288 |
| Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series. |
| Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A |
| European urology. 2020 Jul 2. pii: S0302-2838(20)30507-8. doi: 10.1016/j.eururo.2020.06.047 |
| PMID: 32624281 |
| Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer. |
| Quhal F, Pradere B, Sari Motlagh R, Mori K, Laukhtina E, Aydh A, Mostafaei H, Lysenko I, Schuettfort VM, Stolzenbach F, Palumbo C, Heidenreich A, Briganti A, Karakiewicz PI, Chlosta P, Shariat SF |
| Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2020 Sep 29. pii: S0393-2249.20.03938-7. doi: 10.23736/S0393-2249.20.03938-7 |
| PMID: 32993278 |
| [F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer. |
| Dietlein F, Mueller P, Kobe C, Endepols H, Hohberg M, Zlatopolskiy BD, Krapf P, Heidenreich A, Neumaier B, Drzezga A, Dietlein M |
| Molecular imaging and biology. 2020 Oct 1. doi: 10.1007/s11307-020-01546-0. pii: 10.1007/s11307-020-01546-0 |
| PMID: 33006028 |
| The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy. |
| Quhal F, Abufaraj M, Janisch F, Mori K, Lysenko I, Mostafaei H, D'Andrea D, Mathieu R, Enikeev DV, Fajkovic H, Heidenreich A, Shariat SF |
| Arab journal of urology. 2020 May 31. doi: 10.1080/2090598X.2020.1771947. pii: 1771947. pmc: PMC7717611 |
| PMID: 33312731 |
| [Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]. |
| Paffenholz P, Nestler T, Maatoug Y, von Brandenstein M, Köditz B, Pfister D, Heidenreich A |
| Der Urologe. Ausg. A. 2021 Jan 11. doi: 10.1007/s00120-020-01432-1. pii: 10.1007/s00120-020-01432-1 |
| PMID: 33427889 |
| 71 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
